Bioinspired Dressing Harnesses Cell Pulling to Trigger Targeted Wound Repair
Releasing a patient’s own growth factors only when repair cells tug the material could cut drug doses and ease delivery of advanced wound care.
Overview
- A study published in late July 2026 in Nature Materials reports the first evidence that a force‑responsive dressing works in living repairing tissue and in human skin maintained in the lab.
- The material uses aptamer molecules on a scaffold to capture endogenous growth factors and then releases them only when repair cells apply traction by pulling on the dressing.
- Preclinical tests showed improved vascular growth in a rat femur injury, smaller wound diameter in mouse skin after ten days, and greater tissue ingrowth in ex vivo human skin from abdominoplasty donors.
- The design concentrates and protects the body’s own proteins so therapeutic activity occurs at much lower effective doses—hundreds to thousands of times lower and more than 2,000 times lower than a clinical growth‑factor product—which could reduce reliance on manufactured biologics and cold‑chain storage.
- Imperial College London researchers have launched a spinout, Traxion Biotech, and are in early partner discussions to move the work toward clinical testing, but the technology remains at a preclinical translation stage and must clear regulatory, manufacturing, and larger‑scale studies before human use.